These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 6233938)
1. [Anti-tumor activity of peripheral lymphocytes of tumor-bearing rats by in vitro culture]. Horie K; Yamasaki T; Nishimura K; Tsuchiya S; Yoshizawa A; Akimoto R; Watanabe H; Shirasawa K; Suzuki M; Tsujimoto Y Gan To Kagaku Ryoho; 1984 Jun; 11(6):1269-75. PubMed ID: 6233938 [TBL] [Abstract][Full Text] [Related]
2. [A basic study on the anti-tumor activity of peripheral lymphocytes of tumor-bearing rats by in vitro culture]. Horie K Nihon Geka Gakkai Zasshi; 1985 Jul; 86(7):787-801. PubMed ID: 2931583 [TBL] [Abstract][Full Text] [Related]
3. [Induction of activated macrophages by intraperitoneal injection of mitomycin C in mice and rats]. Ogura T Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):689-96. PubMed ID: 3083782 [TBL] [Abstract][Full Text] [Related]
4. Rejection of syngeneic tumor cells by the interaction of Lyt-1+ T lymphocytes and macrophages. Mitani M; Matsumoto T; Mori K; Miake S; Himeno K; Nomoto K J Clin Lab Immunol; 1985 Oct; 18(2):97-101. PubMed ID: 3935795 [TBL] [Abstract][Full Text] [Related]
5. Cytotoxicity tests against cultured human lung cancer cells with autologous lymphocytes activated in vitro by mitomycin C-treated tumor monolayers in the presence of T-cell growth factor. Kimura H; Yamaguchi Y; Kadoyama C; Sato N; Fujisawa T Jpn J Clin Oncol; 1983 Mar; 13(1):3-13. PubMed ID: 6300483 [TBL] [Abstract][Full Text] [Related]
6. [Experimental studies of plasma exchange therapy for malignant tumor]. Suzuki M; Yamasaki T; Watanabe H; Akimoto R; Shirasawa K; Horie K; Tsujimoto Y; Kidokoro T; Kaminagayoshi S; Miyauchi Y Gan To Kagaku Ryoho; 1984 Jan; 11(1):75-80. PubMed ID: 6421244 [TBL] [Abstract][Full Text] [Related]
7. Studies on the suppression of a one-way mixed lymphocyte reaction by mitomycin-C treated responder cells. Victorino RM; Hodgson HJ Immunology; 1980 Jul; 40(3):447-53. PubMed ID: 6448802 [TBL] [Abstract][Full Text] [Related]
8. Nonspecific inhibition of tumor growth in vivo by admixed allogeneic tumor-sensitized lymphoid cells and identical inactivated allogeneic tumor cells. Sendo F; Nakayama M; Gotohda E; Kobayashi J Immunol; 1976 Oct; 117(4):1340-5. PubMed ID: 61998 [TBL] [Abstract][Full Text] [Related]
9. Stimulation of proliferation in mixed cultures of mouse tumor cells and nonimmune peritoneal cells. II. Stimulation of tumor cells by macrophages and of lymphocytes by a tumor cell product. Nelson M; Nelson DS J Natl Cancer Inst; 1985 Mar; 74(3):637-45. PubMed ID: 3919198 [TBL] [Abstract][Full Text] [Related]
10. Intralesional injection of interleukin-2-expanded autologous lymphocytes in melanoma and breast cancer patients: a pilot study. Adler A; Stein JA; Kedar E; Naor D; Weiss DW J Biol Response Mod; 1984 Oct; 3(5):491-500. PubMed ID: 6334137 [TBL] [Abstract][Full Text] [Related]
11. Multiple roles of interferon-gamma in the mediation of interleukin 12-induced tumor regression. Ogawa M; Yu WG; Umehara K; Iwasaki M; Wijesuriya R; Tsujimura T; Kubo T; Fujiwara H; Hamaoka T Cancer Res; 1998 Jun; 58(11):2426-32. PubMed ID: 9622084 [TBL] [Abstract][Full Text] [Related]
12. Effect of glutamine and chemotherapy on protein metabolism in tumor-bearing rats. Kaibara A; Yoshida S; Yamasaki K; Ishibashi N; Kakegawa T J Surg Res; 1994 Jul; 57(1):143-9. PubMed ID: 8041129 [TBL] [Abstract][Full Text] [Related]
13. Gender dimorphism of macrophage response to GMCSF and IL-4 for differentiation into dendritic cells. Gupta V; Singh SM Am J Reprod Immunol; 2008 Jul; 60(1):43-54. PubMed ID: 18593437 [TBL] [Abstract][Full Text] [Related]
14. [Changes of T lymphocyte subsets in BERH-2 hepatoma-bearing rats and effect of different immunotherapies on the tumor]. Guo YJ Zhonghua Zhong Liu Za Zhi; 1989 May; 11(3):168-71. PubMed ID: 2482158 [TBL] [Abstract][Full Text] [Related]
15. Generation of cytotoxic effector lymphocytes by MLTC using tumor cells genetically modified to secrete interleukin-2. Yamaguchi Y; Ohta K; Shimizu K; Minami K; Noma K; Hihara J; Toge T Anticancer Res; 2001; 21(1B):669-77. PubMed ID: 11299824 [TBL] [Abstract][Full Text] [Related]
16. The anti-human tumor effect and generation of human cytotoxic T cells in SCID mice given human peripheral blood lymphocytes by the in vivo transfer of the Interleukin-6 gene using adenovirus vector. Tanaka F; Abe M; Akiyoshi T; Nomura T; Sugimachi K; Kishimoto T; Suzuki T; Okada M Cancer Res; 1997 Apr; 57(7):1335-43. PubMed ID: 9102222 [TBL] [Abstract][Full Text] [Related]
17. Differential modulation of LAK and ADCC functions of natural killer cells from AK-5 tumor-bearing rats by IL-2, IL-12 and IFN-gamma. Muralikrishna K; Varalakshmi C; Khar A Cytokines Cell Mol Ther; 1997 Mar; 3(1):51-8. PubMed ID: 9287244 [TBL] [Abstract][Full Text] [Related]
18. Factors influencing the autologous mixed lymphocyte reaction in rats: effect of xenogeneic serum protein. Endho N; Hashimoto Y Immunology; 1981 Nov; 44(3):499-507. PubMed ID: 6459288 [TBL] [Abstract][Full Text] [Related]
19. Potent effector function of tumor-sensitized L-selectin(low) T cells against subcutaneous tumors requires LFA-1 co-stimulation. Seeley BM; Barthel SW; To WC; Kjaergaard J; Shu S; Plautz GE Otolaryngol Head Neck Surg; 2001 Apr; 124(4):436-41. PubMed ID: 11283503 [TBL] [Abstract][Full Text] [Related]
20. Immunotherapy of a chemically-induced sarcoma in rats: characterization of the effector T cell subset and nature of suppression. Fernandez-Cruz E; Gilman SC; Feldman JD J Immunol; 1982 Mar; 128(3):1112-7. PubMed ID: 6460058 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]